BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment.

BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment.

Item
http://www.wikidata.org/entity/Q38826206
Atypical antipsychotics: recent research findings and applications to clinical practice: Proceedings of a symposium presented at the 29th Annual European College of Neuropsychopharmacology Congress, 19 September 2016, Vienna, Austria.Depot risperidone-induced adverse metabolic alterations in female rats.The Obesity Epidemic in the Veterans Health Administration: Prevalence Among Key Populations of Women and Men Veterans.Antipsychotic-associated weight gain: management strategies and impact on treatment adherence.Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis.Reversal of olanzapine-induced weight gain in a patient with schizophrenia by switching to asenapine: a case report.Dispensability of Annual Laboratory Follow-Up After More than 2 Years of Valproic Acid Use: A Systematic Review.Monitoring and Treating Metabolic Abnormalities in Patients with Early Psychosis Initiated on Antipsychotic Medications.Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment.CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine.Metabolic Syndrome and Antipsychotics: The Role of Mitochondrial Fission/Fusion Imbalance.Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.
P2860

BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment.

Item
http://www.wikidata.org/entity/Q38826206
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
BAP guidelines on the manageme ...... antipsychotic drug treatment.
@en
type
label
BAP guidelines on the manageme ...... antipsychotic drug treatment.
@en
prefLabel
BAP guidelines on the manageme ...... antipsychotic drug treatment.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
BAP guidelines on the manageme ...... d antipsychotic drug treatment
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921